{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-26-000012","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.661485+00:00","generated_at":"2026-05-16T01:39:44.701235+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bio-Rad updates Sartorius AG 2025 financials: sales €3.54B, net profit €230M","bullets":["Sartorius AG 2025: sales €3,538.1M, gross profit €1,636.7M, EBIT €542.6M, net profit €230.4M.","Balance sheet: current assets €1,766.2M, non-current €7,951.1M, total equity €3,867.2M.","Operating cash flow €837.0M; investing outflow €513.7M; financing outflow €591.4M.","Update follows Sartorius’ Feb 16, 2026 release; Bio-Rad’s 10-K investment disclosure updated accordingly."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-26-000012","json":"https://secwatch.observer/filing/0000012208-26-000012.json","markdown":"https://secwatch.observer/filing/0000012208-26-000012.md","text":"https://secwatch.observer/filing/0000012208-26-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/0000012208-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/bio-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:39:44.701235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}